![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 22, 19938-19945, May 31, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, December 21, 2001, and in revised form, February 11, 2002
The NAD+-dependent
non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase (GAPN)
from the hyperthermophilic archaeum Thermoproteus tenax
represents an archaeal member of the diverse superfamily of aldehyde
dehydrogenases (ALDHs). GAPN catalyzes the irreversible oxidation of
D-glyceraldehyde 3-phosphate to 3-phosphoglycerate. In this
study, we present the crystal structure of GAPN in complex with its
natural inhibitor NADP+ determined by multiple anomalous
diffraction methods. The structure was refined to a resolution of 2.4 Å with an R-factor of 0.21. The overall fold of GAPN is
similar to the structures of ALDHs described previously, consisting of
three domains: a nucleotide-binding domain, a catalytic domain, and an
oligomerization domain. Local differences in the active site are
responsible for substrate specificity. The inhibitor NADP+
binds at an equivalent site to the cosubstrate-binding site of other
ALDHs and blocks the enzyme in its inactive state, possibly preventing
the transition to the active conformation. Structural comparison
between GAPN from the hyperthermophilic T. tenax and homologs of mesophilic organisms establishes several characteristics of
thermostabilization. These include protection against heat-induced covalent modifications by reducing and stabilizing labile residues, a
decrease in number and volume of empty cavities, an increase in
The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase
(GAPN)1 from the
hyperthermophilic archaeum Thermoproteus tenax (Tt-GAPN) catalyzes the NAD+-mediated phosphate-independent
irreversible oxidation of D-glyceraldehyde 3-phosphate
(D-GAP) to 3-phosphoglycerate. The enzyme is
regulated by a number of effectors that modulate the binding of its
cosubstrate NAD+. NADH and ATP lower the affinity for
NAD+, whereas AMP, ADP, glucose 1-phosphate, and fructose
6-phosphate increase the affinity. All effectors induce positive
cooperativity, with NADH showing the highest Hill coefficient of all
effectors of 1.9. Due to its allosteric properties, Tt-GAPN plays a
crucial role in regulating carbohydrate catabolism, thus enabling the organism to respond immediately to physiological requirements (1).
Generally, the activity of GAPN is counteracted by the NADP+-dependent phosphorylating
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which preferentially
exerts anabolic functions. In contrast to GAPN, which is expressed at
similar levels under heterotrophic and autotrophic conditions in
T. tenax, GAPDH is preferentially expressed under
autotrophic conditions. Thus, the regulation of both enzymes occurs at
different levels, allowing a short-term and a long-term adaptation to
changing physiological requirements and growth conditions (2).
Although the phosphorylating T. tenax GAPDH belongs to the
archaeal family of classical phosphate-dependent GAPDHs,
sequence analyses suggested that Tt-GAPN is a member of the superfamily of aldehyde dehydrogenases (ALDHs) (3). These enzymes catalyze the
irreversible oxidation of aldehydes to their respective carboxylic acids. The highest sequence identities are found for other
D-GAP-specific ALDHs from bacteria as well as plants (1).
In contrast to these NADP+-dependent enzymes,
Tt-GAPN explicitly uses NAD+ as cosubstrate and moreover
exhibits allosteric properties that have not been described for any
other ALDH yet investigated (1).
Recently, ALDHs have been of considerable interest because human ALDHs
are involved in physiological impairments such as alcoholism, Sjögren-Larsson syndrome, and carcinogenesis (3). Their broad substrate variety also lends them great biotechnological potential. Crystal structures of ALDHs have been solved for members of class 1 (4,
5), class 2 (6), class 3 (7), and class 9 (8) ALDHs; for the class
3-related enzyme from Vibrio harvei (9); and for GAPN
from Streptococcus mutans (Sm-GAPN) (10). Although the sequence identities for the different classes can be as low as
20%, the structures determined so far adopt the same basic fold
comprising three domains, one dinucleotide-binding domain, one
catalytic domain, and one oligomerization domain. Unlike the classical
Rossmann fold, the nucleotide-binding domain of ALDHs consists of only
five parallel The catalytic mechanism of ALDHs can be described as a two-step
mechanism consisting of acylation and deacylation of an active cysteinyl residue (11). The acylation involves the formation of a
thiohemiacetal intermediate, followed by hydride transfer and reduction
of the pyridine nucleotide. Subsequently, the resulting thioacyl
intermediate is hydrolyzed, and the product and the reduced cosubstrate
are released. Despite many biochemical and mutagenesis studies, the
mechanism and the role of putatively essential residues of this
reaction remain to be elucidated at a molecular level (12). For
instance, the invariant Glu268 (numbering according to
class 2 ALDH) has been implied to function as a general base,
deprotonating the active-site cysteine in class 2 ALDH (6). In class 3 ALDH, however, this residue seems to be involved only in cosubstrate
binding. In the case of Sm-GAPN, this residue has been suggested to
play an essential role in deacylation by activating a water that
hydrolyzes the intermediate (53).
In this work, the crystal structure of Tt-GAPN in complex with its
natural inhibitor NADP+ is presented. The structure was
solved by multiple anomalous diffraction and refined to a resolution of
2.4 Å with a crystallographic R-factor of 0.21. This
represents the first crystal structure of a hyperthermophilic archaeal
member of the ALDH superfamily and allows us to investigate the
structural basis for substrate specificity and allosteric
properties. Detailed comparisons of Tt-GAPN, which exhibits a half-life
of thermoinactivation of ~30 min at 100 °C, with homologous
enzymes from mesophilic organisms have been performed to unravel the
characteristics of thermostabilization.
Protein Expression, Purification, and Crystallization--
The
protein was expressed in Escherichia coli and purified as
described previously (1). Crystals were obtained by the hanging drop
vapor diffusion method with 2.0 M sodium formate as a
precipitating agent. The crystals belong to the hexagonal space group
P6222, with unit cell dimensions of a = b = 185.2 Å and c = 132.1 Å (13). The
selenium-methionine-substituted protein was produced using standard
methods and purified by the same protocol developed for the wild-type
protein (13). Full incorporation of selenium-methionine was verified by
mass spectrometric analysis (data not shown), and the protein was
crystallized under the same conditions as the wild-type protein.
X-ray Data Collection and Processing--
The crystals were
frozen in a rayon loop using the reservoir solution plus 15-25% (v/v)
glycerol as a cryoprotectant (14). All diffraction data were collected
at cryogenic temperatures. The multiple anomalous diffraction data were
collected on the European Molecular Biology Laboratory wiggler beam
line BW7A equipped with a Mar300 imaging plate scanner. A native data
set to a resolution of 2.4 Å was collected on the wiggler beam line
BW7B with a Mar345 imaging plate scanner (15). All images were
processed with DENZO and SCALEPACK (16). Integrated intensities were
converted into structure factors using TRUNCATE (17), which is part of
the CCP4 package (18). Further data collection statistics are
summarized in Table I.
Structure Solution and Refinement--
As no suitable search
model was available at the time of data collection, the structure was
solved by multiple anomalous diffraction phasing. Eight of nine
possible selenium positions were identified using the programs SHELXD
(19) and SOLVE (20). SOLVE was used to refine the positions and to
calculate an initial experimental map with a figure of merit of 0.56 at
a resolution of 2.9 Å. The map was further improved by density
modification using a solvent content of 0.75 with DM (21). This
procedure increased the figure of merit to 0.79, and the resulting
electron density map was readily interpretable. The complete protein
model was built into the experimental map using the interactive
graphics program O (22). The model was refined against the native data
set using the maximum likelihood target function implemented in CNS
(23). The refinement using data from 30 to 2.4 Å was completed by
iterative cycles of model building and simulated annealing (24) and
conjugate gradient least-squares coordinate and restrained
B-factor refinement. The solvent model for low resolution
data and an anisotropic overall B-factor correction of the
program CNS were applied. During all steps of the refinement, 5%
of the data were used to calculate the free R-factor
(25). Further statistics describing the crystallographic refinement are
summarized in Table II.
Quality of the Model--
The final model contains 499 residues
(positions 3-501), one NADP+ molecule, one sodium ion, and
385 solvent molecules. The first two residues are not defined in the
density map and are presumably disordered. The side chains of
residues 3, 319, 328, and 499-501 are not visible in the electron
density map and were thus refined as alanines. The model
possesses good geometry, with 90% of all residues in the most
favored and 9.6% in the allowed regions of the Ramachandran plot as
indicated by the program Procheck (26) (data not shown). The two
residues (Lys466 and Phe471) that are in
generously allowed regions are located in a flexible loop. The r.m.s.
deviations for bond lengths and angles compared with the standard
values of Engh and Huber (27) are 0.009 Å and 1.48°, respectively.
The refinement converged to a crystallographic R-factor of
0.21 (Rfree = 0.24).
Overall Structure and Comparison with ALDH Structures--
The
crystal structure of the Tt-GAPN monomer is shown as a ribbon diagram
in Fig. 1a, with the
annotation of secondary elements given in Fig.
2. The monomer is
composed of three domains that are present in all ALDHs analyzed so
far. The cosubstrate-binding domain consists of a central parallel
five-stranded
Structural comparison of Tt-GAPN was performed using the crystal
structures of dimeric class 3 ALDH from rat (sequence identity of
21.2% (28)) (7), tetrameric class 2 bovine ALDH (28.5%) (6), and
Sm-GAPN (33.9%) (10). The superposition of Tt-GAPN and ALDHs based on
the structural alignment by DALI (29) results in r.m.s. deviations of
2.4 Å for class 2 ALDH and 2.5 Å for class 3 ALDH. The central
As expected from the higher sequence identity, the structures of
Tt-GAPN and Sm-GAPN show the highest similarity. The superposition of
structurally equivalent C Tetramer Formation--
In the crystal structure presented here,
the functional Tt-GAPN tetramer is generated by the crystallographic
222 symmetry (Fig. 1b). This tetramer can be described as a
dimer of two equivalent dimers (A-B, shown in magenta and
blue; and C-D, depicted in orange and
green) that form extensive interactions mainly via the
oligomerization domain (shown in darker shades of the same color in
Fig. 1b). Strand NADP+ Binding--
Tt-GAPN utilizes NAD+
exclusively as a cosubstrate, whereas NADP+ acts as strong
inhibitor (KD = 1 µM). Inhibitor
binding reduces the affinity for the cosubstrate and induces positive cooperativity of NAD+ binding (1). Although no
NADP+ was added during the enzyme purification and
crystallization, the experimental electron density map
unambiguously revealed NADP+ as a ligand (Fig.
4a). We assume that the
inhibitor remained bound to the protein throughout the isolation,
purification, and crystallization of the enzyme. The adenine
dinucleotide phosphate is well defined in the electron density
map, whereas the nicotinamide moiety shows weaker density (Fig.
4a), which is also reflected by higher B-factors.
NADP+ is located in a small pocket and is stabilized by a
number of salt bridges and hydrogen bonds to the protein. The oxygen
atoms of the 2'-phosphate form hydrogen bonds to the main chain
nitrogen atoms of Ile194 and Gly224 and to the
N Active Site--
A number of residues that have been implied to be
essential for the catalytic reaction in ALDHs are conserved in Tt-GAPN, suggesting that the molecular mechanism of catalysis is likely to be
similar (see conserved active-site residues in Fig. 2). According to
the reaction mechanism suggested by Marchal et al. (53),
Cys297 (corresponding to Cys284 in Sm-GAPN)
performs the nucleophilic attack on the aldehyde group of the substrate
to form the thiohemiacetal. Asn168
(Asn154) then stabilizes the intermediate and
facilitates the transfer of the hydride to the cosubstrate.
Glu263 (Glu250) activates the subsequent
deacylation step by directed hydrolysis of the thioester bond. However,
in the conformation observed in the crystal structure presented here,
the distance between the side chain atoms of Glu263 and
Cys297 is ~6 Å (Fig. 5).
In addition, the nicotinamide ring of NADP+ is located between
these two residues, thus blocking any potential interaction. In the
case of Sm-GAPN, the binding of D-GAP induces, however, a
structural change to the active conformation as shown by the crystal
structure of the active-site variant C284S Sm-GAPN in complex with NADP
and D-GAP. The superposition of the binary complex of
Tt-GAPN and the ternary complex of C284S Sm-GAPN shows that a similar
conformational change would also allow the reaction in Tt-GAPN. In the
case of Tt-GAPN, the tight binding of NADP+ may block this
conformational change from the inactive binary complex to its active
form.
The substrate-binding pocket of C284S Sm-GAPN reveals that
D-GAP is bound by a number of ionic interactions to the
phosphate (e.g. by Arg103, Tyr155,
and Arg283) and to the carbonyl oxygen at C-1
(Asn154 and Ser284) (12). However, because
Sm-GAPN uses both D-GAP and L-GAP as substrate,
the interaction between Arg437 and the chiral C-2 does not
confer any stereospecificity. The structure of Tt-GAPN, which uses only
D-GAP as a substrate, possesses a similar anion-binding
pocket, however, with significant differences. The equivalent residue
of Arg437 is a histidine (His455) that is
turned away from the putative substrate-binding site and forms a salt
bridge to Asp424. The main chain residues 456-459 adopt a
remarkably different orientation (Fig. 5), with equivalent atoms of
this loop differing by up to 5 Å between the Tt-GAPN and Sm-GAPN
structures. It is important to note that this loop possesses the same
conformation in the binary wild-type Sm-GAPN and ternary C284S Sm-GAPN
structures. These structural changes observed are therefore not due to
substrate binding and may thus be responsible for the stereoselectivity of Tt-GAPN. In the structure presented here, the
D-GAP-binding site is filled with three water molecules
that mimic the position of the substrate. The exact reason for
stereospecificity cannot be determined, but it is likely that
Tt-GAPN-specific features such as His455 and the
conformation of the loop region of residues 456-459 are involved.
Clearly, further structural studies of Tt-GAPN in complex with its
substrate are needed to answer this question.
Allosteric Regulation--
The distance between the
cosubstrate-binding sites in the Tt-GAPN tetramer is ~30 Å for the
A-B and C-D dimers. Thus, it is unlikely that there is a direct
connection between these two sites to induce cooperativity. Presumably,
an overall motion of domains or even monomers with respect to each
other is responsible for cooperative binding. The effector molecules
such as AMP, ADP, and glucose 1-phosphate bind most likely at a
different site than the cosubstrate sites determined in the current
structure. Binding of the effector might then induce a conformational
change in the enzyme to the active conformation. Further structural
studies of Tt-GAPN in complex with its allosteric regulators are needed to unravel their mode of action.
Determinants for Protein Stability--
Although no general
strategy of thermostability has been established, it has become clear
that all levels of protein structure from primary to quaternary
structure may contribute to thermal stabilization (30-33). We will
identify below individual determinants for thermostability in Tt-GAPN
by comparing its crystal structure with those of mesophilic homologs,
viz. Sm-GAPN (10) and class 2 bovine ALDH (6).
At elevated temperature, damage to the covalent structure is of
particular importance, with several residues known to be prone to
irreversible chemical reactions. Asparagine and glutamine residues are
susceptible to deamidation of the side chain and cleavage of the
peptide bond, and cysteine is vulnerable to oxidation and
Electrostatic interactions have often been implied to be important for
thermal stability (36). The higher number of charged residues in
Tt-GAPN does not lead to an increase in the number of intramolecular
salt bridges (Table III); but more charged residues are engaged in
intermolecular interactions, and the total number is considerably
higher in the hyperthermophilic enzyme than in the mesophilic ones. On
the other hand, the number of hydrogen bonds per tetramer is not
increased in Tt-GAPN (Table IV). These results correspond well with a comprehensive study by Szilagyi and
Zavodszky (37), which revealed a clear preference for salt bridges, but no increase in hydrogen bonding in hyperthermophilic enzymes.
Structural comparison of Tt-GAPN with its mesophilic homologs reveals a
considerable decrease in the number and volume of empty cavities.
Hyperthermophilic Tt-GAPN possesses no internal cavities >2
Å3, whereas the mesophilic homologs exhibit more and
larger cavities (Table III). According to estimates by Eriksson
et al. (38), the higher packing density would result in a
gain of free energy of ~1-2 kcal/mol and thus would
thermodynamically stabilize the protein. A similar tendency toward
fewer cavities in hyperthermophilic enzymes has also been noted
previously (37).
In hyperthermophilic proteins, the N and C termini are often more
tightly bound, or even buried, to avoid initiation of thermal unfolding
(39). This may lead to a kinetic stabilization of the protein. In
Tt-GAPN, however, the N terminus is solvent-exposed, and the first
three residues are invisible in the electron density map. The
observed flexibility may represent a weak point in the current
structure. The enzyme that is directly isolated from T. tenax cells is N-terminally blocked and shows higher thermal
stability compared with the recombinant protein. Hence, the chemical
modification may be responsible for the higher thermal stability by
restricting the N-terminal flexibility. In contrast to the
solvent-exposed N terminus, the prolonged C terminus is integrated in
the hydrophobic subunit contact area and may thus confer stability to
the tetramer.
Shortening and deletion of loops have been described as characteristic
features of thermophilic proteins (40). The structure-based sequence
alignment (Fig. 2) shows that the loops of the hyperthermophilic and
mesophilic enzymes generally are of similar lengths; and consequently, loop shortening does not appear to contribute to the thermal stability of Tt-GAPN. At the secondary structural level, the Tt-GAPN structure follows the trend toward a higher percentage of
Intersubunit stabilization of oligomeric proteins has been considered
more recently to represent one of the main factors in evolutionary
strategies of thermoadaptation (46). Along with a series of recent
reports that emphasize the importance of electrostatic and hydrophobic
subunit interactions in hyperthermophilic oligomeric proteins (46), our
comparison of subunit contacts of Tt-GAPN with its mesophilic homologs
revealed remarkably increased hydrophobic interactions as well as a
higher number of salt bridges (Table IV). Clearly, these two factors
contribute significantly to thermostability.
We are grateful to D. Lang for the initial
contribution to this work. We also thank M. Wilm for the mass
spectrometric analysis, R. van Silfhout and O. Mayans for support
during data collection, and E. Lorentzen and P. Tucker for critically
reading the manuscript and many valuable discussions.
*
This work was supported by Deutsche Forschungsgemeinschaft
Grant He 1238/14-1.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1KY8) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
§
To whom correspondence may be addressed. Tel.: 49-40-89902-192;
Fax: 49-40-89902-149; E-mail: ehmke@embl-hamburg.de.
**
To whom correspondence may be addressed. Tel.:
49-201-1833442; Fax: 49-201-1833990; E-mail:
r.hensel@uni-essen.de.
Published, JBC Papers in Press, February 12, 2002, DOI 10.1074/jbc.M112244200
The abbreviations used are:
GAPN, non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase;
Tt-GAPN, T. tenax GAPN;
Sm-GAPN, S. mutans GAPN;
D-GAP, D-glyceraldehyde 3-phosphate;
GAPDH, phosphorylating glyceraldehyde-3-phosphate dehydrogenase;
ALDH, aldehyde dehydrogenase;
r.m.s., root mean square.
The Crystal Structure of the Allosteric Non-phosphorylating
Glyceraldehyde-3-phosphate Dehydrogenase from the Hyperthermophilic
Archaeum Thermoproteus tenax*
§,
,
, and
European Molecular Biology Laboratory,
Hamburg Outstation, Notkestraße 85, D-22603 Hamburg, Germany and the
¶ Department of Microbiology, University of Essen,
Universitätsstraße 5, D-45117 Essen, Germany
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-strand content, and a strengthening of subunit contacts by ionic
and hydrophobic interactions.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-strands. The interaction between the pyrophosphate
moiety of the nucleotide and the protein occurs via the loop between
strand
J and helix
8. This arrangement results in a significantly different conformation of the cosubstrate compared with proteins with the Rossmann fold. The catalytic domain adopts an
/
-fold and contains the conserved active-site cysteine. The oligomerization domain is responsible for dimer and tetramer formation.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
Summary of data collection statistics for the multiple anomalous
diffraction and the native data sets of Tt-GAPN
Summary of refinement statistics of the native Tt-GAPN data at
2.4-Å resolution
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-sheet (
K,
J,
G,
H, and
I) surrounded by
five helices (
1,
5,
6,
7, and
8) (shown in blue) and
a small N-terminal antiparallel
-sheet (
A,
B,
C, and
D) (shown in
green). The catalytic domain (residues 266-441 shown in
yellow) adopts an
/
-fold with the central parallel
-sheet of
L to
X and helices
9 to
13. This domain contains the
active-site cysteine (Cys297) that is highly conserved in
the ALDH superfamily and the loop region of residues 455-460 that is
implicated in substrate specificity (orange). The
oligomerization domain is composed of three antiparallel
-strands
(red). Two of these strands (
E and
F) are part of the N-terminal half, whereas the third
strand (
Z) originates from the C terminus. The remaining
nine C-terminal residues are wrapped around the turn of the first two
-strands.

View larger version (37K):
[in a new window]
Fig. 1.
a, ribbon diagram of the crystal
structure of the Tt-GAPN monomer. The N-terminal
-sheet of the
cosubstrate-binding domain is shown in green; the remaining
part of this domain is in blue. The catalytic domain is
depicted in yellow, and the oligomerization domain is in
red. The loop region of residues 455-460 that may be
responsible for specificity is shown in orange.
NADP+ is shown in a red ball-and-stick
representation. b, ribbon diagram of the crystallographic
tetramer. Each symmetry equivalent monomer is depicted in one color:
monomer A, magenta; monomer B, blue; monomer C,
orange; and monomer D, green. The three strands
of the oligomerization domain in each subunit in the center of the
figure are depicted in darker shades of the same color. The inhibitors
bound in each monomer have been omitted for clarity. All figures were
prepared using Molscript (47); its extended version, Bobscript (48);
and/or raster3d (49).

View larger version (69K):
[in a new window]
Fig. 2.
Structure-based sequence alignment of
Tt-GAPN, Sm-GAPN (10), and class 2 bovine ALDH (6) using DALI
(29). The secondary structure elements of the Tt-GAPN structure
are indicated by boxes (
-helices) and arrows
(
-strands). The residues with a gray background are
structurally equivalent. The active-site residues are highlighted in
red; the residues involved in NADP+ binding in
yellow; and the important loops of the active site in
green. Tt, Tt-GAPN; Sm, Sm-GAPN;
bov, class 2 bovine ALDH.
-sheets of the cosubstrate-binding and catalytic domains superimpose
well, with r.m.s. deviations of only ~1 Å for equivalent
C
atoms. The GAPN-specific sequences (1) that are not
found in any ALDH superimpose generally well with the corresponding residues in the ALDH structure. The C
atoms of the
active-site loop (residues 294-297, shown in green in Fig.
2) are within 1 Å after the least-squares superposition of the
C
backbone. However, larger differences of >5 Å for
equivalent C
atoms can be found in the flanking helices
and the connecting loops. The largest differences occur in the first 20 residues that form two short antiparallel
-strands in Tt-GAPN. In
class 2 bovine ALDH, the equivalent residues adopt a random coil
conformation pointing into the solvent.
atoms results in a r.m.s.
deviation of 1.6 Å. The largest differences can be seen in the loop
regions, whereas the cores of the catalytic and cosubstrate-binding
domains superimpose very well, with deviations of <1 Å for the main
chain atoms (Fig. 3). The Tt-GAPN
structure possesses longer termini and seven deletions and insertions
compared with Sm-GAPN. The first 14 N-terminal residues in Tt-GAPN are folded back over the N-terminal sheet and form an antiparallel
-strand with residues 10-14 and one helical turn (residues 4-6). In addition, there are four one-amino acid insertions
(Lys65, Lys132, Thr333, and
Leu369) and three deletions (following Ala126,
Asp141, and Lys225) that do not lead to large
structural changes. The largest insertion of three amino acids
(Ala383-Arg385) is located in helix
12 of the catalytic domain and is simply accommodated by
an additional N-terminal turn of the helix. The C terminus of Tt-GAPN
is also extended by eight amino acids compared with Sm-GAPN. These
residues are folded back over strands
E and
F of the oligomerization domain.

View larger version (38K):
[in a new window]
Fig. 3.
Least-squares superposition of
structurally equivalent C
atoms of
Tt-GAPN (red) and Sm-GAPN (blue)
(10).
X from the catalytic domain
of subunit A interacts with strand
Z from the
oligomerization domain of subunit B. These two strands are thus part of
a 10-stranded parallel
-sheet structure extending through both the
catalytic and oligomerization domains. There are additional contacts
between the helix
A and its symmetry mate. The A-B
interface has a buried surface of ~3000 Å2 and is mainly
composed of hydrophobic residues. The tetramer is completed by weaker
interaction between the two dimers A-B and C-D. The equivalent A-C and
B-D interfaces provide the smallest subunit contact with a buried
surface of 840 Å2 for each interface. This
interface is stabilized by hydrophobic interactions of residues
Leu130 and Lys131, which are located at the
beginning of the tetramerization domain to their symmetry-related
residues. In addition, helix
14 of the catalytic domain
interacts with C-terminal residues 492-498 via hydrophobic contacts
between Val433 and the methylene groups of
Arg436 on one side and between Tyr492' and the
methylene groups of Lys495' and Val497' on the
other side. This contact is extended into the first domain by a salt
bridge from Arg436 to Asp150. The A-D and B-C
dimer interfaces are composed of the following two sets of
interactions: (i) strand
E of each oligomerization domain forms a
-sheet with its symmetry-related strand, and (ii) the
loop region of residues 430-432 interacts with its symmetry-related counterpart through four hydrogen bonds (Arg430
N
-Asp431' O
2 and
Arg430 O-Val432' N). The overall buried
surface of the A-D (and the B-C) interface amounts to 1340 Å2. In the center of the Tt-GAPN tetramer, a large 1080 Å3 cavity filled with well defined solvent molecules can
be found. A similar feature is found in the Sm-GAPN structure; but, due to the smaller contact surface in Sm-GAPN, the space is
solvent-accessible through open channels.
atom of Lys191 and the O
atom of Ser193 (Fig. 4b). In addition, the
3'-hydroxyl group is hydrogen-bonded to the carbonyl oxygen of
Thr165. The diphosphate moiety forms one hydrogen bond to
the main chain nitrogen of Ser244 as well as one to the
side chain O
. The 2'- and 3'-hydroxyl groups of the
ribose ring at the nicotinamide are hydrogen-bonded to the
Glu395 side chain oxygen atoms. Because this residue is
strictly conserved (Fig. 2), it has been suggested that this
interaction is responsible for directing the cosubstrate orientation
(9). The nicotinamide group is connected to the O
2 atom
of Glu263 and the main chain nitrogen atom of
Gly265 by additional hydrogen bonds. These two interactions
appear to stabilize the conformation observed in the crystal. As the
binding site of NADP+ is similar to the cosubstrate-binding
site identified previously in ALDH crystal structures (6, 10), the
NAD+ cosubstrate of GAPN is most likely bound in the same
pocket. This assumption is further confirmed by the observation of a
similar position and conformation of NADP+ in the Tt-GAPN
and Sm-GAPN structures (Fig. 4c) and comparable protein-ligand contacts. Remarkably, the Sm-GAPN structure shows an
additional hydrogen bond from the O
atom of the
Thr180 side chain to the phosphate, which is not present in
the Tt-GAPN structure; and it has been speculated that this interaction
is responsible for NADP+ selectivity over NAD+
(10). The loss of this hydrogen bond is, however, compensated by two
additional hydrogen bonds to the 2'-phosphate of NADP+: (i)
the side chain oxygen of Ser193 and (ii) the main chain
nitrogen of Gly224 serve as hydrogen donors for the
negatively charged phosphate as described above.

View larger version (26K):
[in a new window]
Fig. 4.
a, stereo view of a representative
portion of the experimental electron density map after solvent
flattening at a 1.5-
level showing the inhibitor-binding site. The
final model of NADP+ is superimposed as a ball-and-stick
representation. b, close-up stereo view of the binding site
showing the hydrogen bonds between the phosphate and protein atoms. The
nicotinamide moiety has been omitted for clarity. c,
position of NADP+ in the structures of Tt-GAPN (gray
bonds) and Sm-GAPN (white bonds) after the
least-squares superposition of the C
trace of the two
enzymes.

View larger version (21K):
[in a new window]
Fig. 5.
Stereo view of the active site after
the superposition of the crystal structures of Tt-GAPN and
C284S Sm-GAPN in complex with its substrate
determined at 3-Å resolution (12). NADP+, which is
present in both structures, has been omitted for clarity. The
C
trace of the loop region of residues 454-460
in Tt-GAPN is shown in red; the corresponding loop in
Sm-GAPN (residues 436-442) is shown in blue.
-elimination (34, 35). Consequently, there are fewer of these residues in Tt-GAPN compared with its mesophilic homologs (Table III). Nearly all of the remaining Asn and
Gln side chains are hydrogen-bonded to other protein atoms, thus
providing additional protection against irreversible damage. These
hydrogen bonds stabilize the residues in a conformation that may
prevent destruction. Certain sequence motifs that are known to promote
asparagine-related damage (e.g. Asn-Gly, Asn-Ser, Asn-Thr,
and Ser-Asn) (34) are also rare. Tt-GAPN contains only one of these
motifs (at residues 417 and 418), and it is stabilized by two hydrogen
bonds of the Asn417 side chain to main chain atoms. In
contrast to Tt-GAPN, class 2 bovine ALDH contains three and Sm-GAPN
contains six of these "hot spots." The only cysteine that remains
in Tt-GAPN is the active-site Cys297.
Structural features of the monomers of hyperthermophilic Tt-GAPN,
mesophilic Sm-GAPN, and class 2 bovine ALDH
Tetramer formation of hyperthermophilic Tt-GAPN, mesophilic
Sm-GAPN, and class 2 bovine ALDH
-strands compared with its mesophilic counterparts (Table III). However, there is no
notable increase in
-helical content. In this respect, our results
confirm previous comparative studies (37, 41). Additional indications
of helix stabilization that have been described such as a decrease in
-branched residues (42), an increase in intrahelical salt bridges
(43), and a preference for N-capping residues such as Thr, Asp, Ser,
and Gly (44) are not found in the Tt-GAPN structure. Only prolines seem
to be slightly more numerous in hyperthermophilic GAPN, with five
N-capping prolines compared with none in Sm-GAPN and two in class 2 bovine ALDH. Prolines at this particular position have been found to be
only marginally favored in general and are slightly preferred in the
so-called Pro box motif (hPXXhh) (45). None of the
N-capping prolines are part of this motif; and hence, these residues
are not expected to provide additional stabilization. Furthermore, the
amino acid composition of loops indicates that conformationally
restraining prolines are more numerous in the hyperthermophilic enzyme
relative to the mesophilic enzymes (Table III). However, there are also more glycines, which provide additional flexibility when Tt-GAPN and
Sm-GAPN are compared. The mesophilic bovine enzyme and Tt-GAPN have the
same number of glycines in loops (Table III). In summary, there is no
clear indication that the loops are stabilized by their amino acid
composition in Tt-GAPN.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Present address: Bayer AG, Business Group Pharma, PH-R-AI 1, D-42096 Wuppertal, Germany.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Brunner, N. A.,
Brinkmann, H.,
Siebers, B.,
and Hensel, R.
(1998)
J. Biol. Chem.
273,
6149-6156 2.
Brunner, N.,
Siebers, B.,
and Hensel, R.
(2001)
Extremophiles
5,
101-109[CrossRef][Medline]
[Order article via Infotrieve]
3.
Yoshida, A.,
Rzhetsky, A.,
Hsu, L. C.,
and Chang, C.
(1998)
Eur. J. Biochem.
251,
549-557[Medline]
[Order article via Infotrieve]
4.
Moore, S. A.,
Baker, H. M.,
Blythe, T. J.,
Kitson, K. E.,
Kitson, T. M.,
and Baker, E. N.
(1998)
Structure
6,
1541-1551[Medline]
[Order article via Infotrieve]
5.
Niederhut, M. S.,
Gibbons, B. J.,
Perez-Miller, S.,
and Hurley, T. D.
(2001)
Protein Sci.
10,
697-706G 6.
Steinmetz, C. G.,
Xie, P.,
Weiner, H.,
and Hurley, T. D.
(1997)
Structure
5,
701-711[Medline]
[Order article via Infotrieve]
7.
Liu, Z. J.,
Sun, Y. J.,
Rose, J.,
Chung, Y. J.,
Hsiao, C. D.,
Chang, W. R.,
Kuo, I.,
Perozich, J.,
Lindahl, R.,
Hempel, J.,
and Wang, B. C.
(1997)
Nat. Struct. Biol.
4,
317-326[CrossRef][Medline]
[Order article via Infotrieve]
8.
Johansson, K., El-,
Ahmad, M.,
Ramaswamy, S.,
Hjelmqvist, L.,
Jornvall, H.,
and Eklund, H.
(1998)
Protein Sci.
7,
2106-2117[Abstract]
9.
Ahvazi, B.,
Coulombe, R.,
Delarge, M.,
Vedadi, M.,
Zhang, L.,
Meighen, E.,
and Vrielink, A.
(2000)
Biochem. J.
349,
853-861
10.
Cobessi, D.,
Tete-Favier, F.,
Marchal, S.,
Azza, S.,
Branlant, G.,
and Aubry, A.
(1999)
J. Mol. Biol.
290,
161-173[CrossRef][Medline]
[Order article via Infotrieve]
11.
Sheikh, S., Ni, L.,
Hurley, T. D.,
and Weiner, H.
(1997)
J. Biol. Chem.
272,
18817-18822 12.
Cobessi, D.,
Tete-Favier, F.,
Marchal, S.,
Branlant, G.,
and Aubry, A.
(2000)
J. Mol. Biol.
300,
141-152[CrossRef][Medline]
[Order article via Infotrieve]
13.
Brunner, N. A.,
Lang, D. A.,
Wilmanns, M.,
and Hensel, R.
(2000)
Acta Crystallogr. Sect. D
56,
89-91[CrossRef][Medline]
[Order article via Infotrieve]
14.
Teng, T. Y.
(1990)
J. Appl. Crystallogr.
23,
387-391[CrossRef]
15.
Silfhout, R. G.,
and Hermes, C.
(1994)
Rev. Sci. Instrum.
66,
1818-1820[CrossRef]
16.
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
17.
French, G. S.,
and Wilson, K. S.
(1978)
Acta Crystallogr. Sect. A
34,
517-520[CrossRef]
18.
Collaborative Computational Project.
(1994)
Acta Crystallogr. Sect. D
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve]
19.
Sheldrick, G. M.
(1998)
in
Direct Methods for Solving Macromolecular Structures
(Fortier, S., ed)
, pp. 401-411, Kluwer Academic Publishers Group, Dordrecht, The Netherlands
20.
Terwilliger, T. C.,
and Berendzen, J.
(1999)
Acta Crystallogr. Sect. D
55,
849-861[CrossRef][Medline]
[Order article via Infotrieve]
21.
Cowtan, K.,
and Main, P.
(1998)
Acta Crystallogr. Sect. D
54,
487-493[CrossRef][Medline]
[Order article via Infotrieve]
22.
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119
23.
Brunger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
24.
Brunger, A. T.,
Krukowski, A.,
and Erickson, J. W.
(1990)
Acta Crystallogr. Sect. A
46,
585-593
25.
Brunger, A. T.
(1993)
Acta Crystallogr. Sect. D
49,
24-36[CrossRef][Medline]
[Order article via Infotrieve]
26.
Laskowski, R. A.,
Moss, D. S.,
and Thornton, J. M.
(1993)
J. Mol. Biol.
231,
1049-1067[CrossRef][Medline]
[Order article via Infotrieve]
27.
Engh, R. A.,
and Huber, R.
(1991)
Acta Crystallogr. Sect. D
37,
392-400
28.
Person, W. R.,
Wood, T.,
Zhang, Z.,
and Miller, W.
(1997)
Genomics
46,
24-36[CrossRef][Medline]
[Order article via Infotrieve]
29.
Holm, L.,
and Sander, C.
(1993)
J. Mol. Biol.
233,
123-138[CrossRef][Medline]
[Order article via Infotrieve]
30.
Matthews, B. W.
(1995)
Adv. Protein Chem.
46,
249-278[Medline]
[Order article via Infotrieve]
31.
Ladenstein, R.,
and Antranikian, G.
(1998)
Adv. Biochem. Eng. Biotechnol.
61,
37-85[Medline]
[Order article via Infotrieve]
32.
Jaenicke, R.,
and Bohm, G.
(1998)
Curr. Opin. Struct. Biol.
8,
738-748[CrossRef][Medline]
[Order article via Infotrieve]
33.
Sterner, R.,
and Liebl, W.
(2001)
Crit. Rev. Biochem. Mol. Biol.
1,
39-106
34.
Wright, H. T.
(1991)
Crit. Rev. Biochem. Mol. Biol.
26,
1-52[Medline]
[Order article via Infotrieve]
35.
Daniel, R. M.,
Dines, M.,
and Petach, H. H.
(1996)
Biochem. J.
317,
1-11
36.
Elcock, A. H.
(1998)
J. Mol. Biol.
284,
489-502[CrossRef][Medline]
[Order article via Infotrieve]
37.
Szilagyi, A.,
and Zavodszky, P.
(2000)
Structure
8,
493-504[Medline]
[Order article via Infotrieve]
38.
Eriksson, A. E.,
Baase, W. A.,
Zhang, X. J.,
Heinz, D. W.,
Blaber, M.,
Baldwin, E. P.,
and Matthews, B. W.
(1992)
Science
255,
178-183 39.
Hennig, M.,
Sterner, R.,
Kirschner, K.,
and Jansonius, J. N.
(1997)
Biochemistry
36,
6009-6016[CrossRef][Medline]
[Order article via Infotrieve]
40.
Thompson, M. J.,
and Eisenberg, D.
(1999)
J. Mol. Biol.
290,
595-604[CrossRef][Medline]
[Order article via Infotrieve]
41.
Kumar, S.,
Tsai, C. J.,
and Nussinov, R.
(2000)
Protein Eng.
13,
179-191 42.
Facchiano, A. M.,
Colonna, G.,
and Ragone, R.
(1999)
Protein Eng.
11,
753-760 43.
Chakravarty, S.,
and Varadarajan, R.
(2000)
FEBS Lett.
470,
65-69[CrossRef][Medline]
[Order article via Infotrieve]
44.
Harpaz, Y.,
Elmasry, N.,
Fersht, A. R.,
and Hendrick, K.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
311-315 45.
Viguera, A. R.,
and Serrano, L.
(1999)
Protein Sci.
8,
1733-1742[Abstract]
46.
Walden, H.,
Bell, G. S.,
Russell, R. J.,
Siebers, B.,
Hensel, R.,
and Taylor, G. L.
(2001)
J. Mol. Biol.
306,
745-757[CrossRef][Medline]
[Order article via Infotrieve]
47.
Kraulis, P.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
48.
Esnouf, R. M.
(1997)
J. Mol. Graph.
15,
132-134[CrossRef][Medline]
[Order article via Infotrieve]
49.
Merritt, E. A.,
and Murphy, M. E. P.
(1994)
Acta Crystallogr. Sect. D
50,
869-873[CrossRef][Medline]
[Order article via Infotrieve]
50.
Vriend, G.
(1990)
J. Mol. Graph.
8,
52-56[CrossRef][Medline]
[Order article via Infotrieve]
51.
Kleywegt, G. J.,
and Jones, T. A.
(1994)
Acta Crystallogr. Sect. D
50,
178-185[CrossRef][Medline]
[Order article via Infotrieve]
52.
Jones, S.,
and Thornton, J. M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13-20 53.
Marchal, S.,
Rahuel-Clermont, S.,
and Branlant, G.
(2000)
Biochemistry
39,
3327-3335[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. S. Rodriguez-Zavala Enhancement of coenzyme binding by a single point mutation at the coenzyme binding domain of E. coli lactaldehyde dehydrogenase Protein Sci., March 1, 2008; 17(3): 563 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Siebers, B. Tjaden, K. Michalke, C. Dorr, H. Ahmed, M. Zaparty, P. Gordon, C. W. Sensen, A. Zibat, H.-P. Klenk, et al. Reconstruction of the Central Carbohydrate Metabolism of Thermoproteus tenax by Use of Genomic and Biochemical Data J. Bacteriol., April 1, 2004; 186(7): 2179 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dorr, M. Zaparty, B. Tjaden, H. Brinkmann, and B. Siebers The Hexokinase of the Hyperthermophile Thermoproteus tenax: ATP-DEPENDENT HEXOKINASES AND ADP-DEPENDENT GLUCOKINASES, TWO ALTERNATIVES FOR GLUCOSE PHOSPHORYLATION IN ARCHAEA J. Biol. Chem., May 23, 2003; 278(21): 18744 - 18753. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marchal and G. Branlant Characterization of the Amino Acids Involved in Substrate Specificity of Nonphosphorylating Glyceraldehyde-3-Phosphate Dehydrogenase from Streptococcus mutans J. Biol. Chem., October 11, 2002; 277(42): 39235 - 39242. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||